Statim

Statim is a free web workspace that combines drug information, FDA adverse event analysis, clinical trial comparisons and a cited Q&A assistant for pharmacists, payers, students and specialists.

Statim is a web workspace that gathers drug reference information, adverse event analysis and clinical trial evidence in one place. It targets professionals who otherwise move between several separate databases to answer a single medication question. Answers are grounded in peer-reviewed sources such as PubMed and the Cochrane Library, alongside FDA data, and they carry citations so a reader can check where each claim came from. The centerpiece is Clinical Safety Intelligence, which analyzes FDA Adverse Event Reporting System data to produce five kinds of structured insight: demographic risk by age band and gender, severity distribution, interaction ratings, adherence and tolerability factors such as dosing complexity and cost, and off-label effects. Those signals are then compared with rates recorded in registered trials on ClinicalTrials.gov, which makes gaps between real-world reporting and trial populations visible. Each insight lists report counts, confidence intervals and citations, and the datasets are versioned with stable identifiers intended for academic publications and AI pipelines. In daily use, people search in natural clinical language instead of exact drug names, ask medication questions in a Q&A assistant that draws on prescribing information, trials and PubMed, and follow new FDA approvals with regulatory tags such as Breakthrough Therapy or Priority Review. Drug profiles can be bookmarked with private notes, and medications with co-pay assistance are flagged for formulary reviews. The site names clinical pharmacists, insurance payers and formulary teams, medical students and residents, and specialists whose EMR runs out of answers as its audience, and it states that no patient data is involved. Among alternatives, Statim sits between static drug directories, which list side effects without context, and general-purpose chatbots, which rarely show structured evidence. It is free to use and built around citations, though it works as a research aid and not as a replacement for clinical judgment.